Both in Pharmaceuticals
Xenon Pharmaceuticals vs Viking Therapeutics
Over the past year XENE returned −13.6% and VKTX returned −30.5%; their daily moves had a correlation of 0.17.
XENE −13.6% VKTX −30.5%Growth of $1, one year, split-adjusted
| Metric | XENE | VKTX |
|---|---|---|
| Price | $36.18 | $24.97 |
| Market cap | $3.50B | $3.18B |
| Today | +0.47% | +0.32% |
| 1 month | −2.9% | −21.5% |
| 6 months | −35.1% | −20.3% |
| Year to date | −19.3% | −29.0% |
| 1 year | −13.6% | −30.5% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $930.7M | $501.7M |
| Dividend yield | — | — |
| Volatility (60d) | 81.9% | 85.8% |
| Short % of float | 8.1% | 22.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).